Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, ...
Cancer has often been explained through mutations in deoxyribonucleic acid (DNA) or changes in ribonucleic acid (RNA), but ...
Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, fueling drug resistance and disease progression.
A previous trial involving patients with metastatic prostate cancer that was resistant to androgen pathway modulation (formerly referred to as castration-resistant) showed that adding talazoparib ...
What if a new combination of cancer drugs could sound an alarm, alerting the body's immune system to invoke a targeted ...
A newly identified interaction between PIM1 and HMGB1 helps prostate cancer cells survive therapy by activating cellular ...
Small RNA therapeutics can modulate multiple genes. This ability may counter tumor adaptation and resistance, overcoming the ...
Researchers at the Medical University of Vienna have described a mechanism in metastatic colorectal cancer that has received little attention to date: A key target of existing therapies, the so-called ...
Social factors presented in the outer circle and physiological factors in the inner circle are common sources of chronic stress. Social factors include poor pre- or post-delivery care, emotional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results